Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human (original) (raw)

• Orr, H.T. et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4, 221–226 (1993).
  Article CAS Google Scholar
• Kawaguchi, Y. et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet 8, 221–228 (1994)
  Article CAS Google Scholar
• Zhuchenko, O. et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α-1A-voltage-dependent calcium channel. Nature Genet. 15, 62–69 (1997).
  Article CAS Google Scholar
• David, G. et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genet. 17, 65–70 (1997).
  Article CAS Google Scholar
• The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983 (1993).
• La Spada, A.R, Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77–79 (1991).
  Article CAS Google Scholar
• Koide, R. et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nature Genet. 6, 9–13 (1994).
  Article CAS Google Scholar
• Cummings, C.J. et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nature Genet. 19, 148–154 (1998).
  Article CAS Google Scholar
• Paulson, H.L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333–344 (1997).
  Article CAS Google Scholar
• Trottier, Y. et al. Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol. Dis. 5, 335–347 (1998).
  Article CAS Google Scholar
• Holmberg, M. et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 7, 913–918 (1998).
  Article CAS Google Scholar
• Igarashi, S. et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet. 18, 111–117 (1998).
  Article CAS Google Scholar
• Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548 (1997).
  Article CAS Google Scholar
• Martindale, D. et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet. 18, 150–154 (1998).
  Article CAS Google Scholar
• Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55–66 (1998).
  Article CAS Google Scholar
• Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549–558 (1997).
  Article CAS Google Scholar
• Stenoien, D.L. et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 8, 731–741 (1999).
  Article CAS Google Scholar
• Reddy, P.H. et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nature Genet. 20, 198–202 (1998).
  Article CAS Google Scholar
• Paulson, H.L. Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis) fold. Am. J. Hum. Genet. 64, 339–345 (1999).
  Article CAS Google Scholar
• Gutekunst, C.A. et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522–2534 (1999).
  Article CAS Google Scholar
• Kuemmerle, S. et al. Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46, 842–849 (1999).
  Article CAS Google Scholar
• Klement, I.A. et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41–53 (1998).
  Article CAS Google Scholar
• Cummings, C.J. et al. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879–892 (1999).
  Article CAS Google Scholar
• Ishikawa, K. et al. Abundant expression and cytoplasmic aggregations of [α]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet. 8, 1185–1193 (1999).
  Article CAS Google Scholar
• Nechiporuk, T. et al. The mouse SCA2 gene: cDNA sequence, alternative splicing, and protein expression. Hum. Mol. Genet. 7, 1301–1309 (1998).
  Article CAS Google Scholar
• Imbert, G. et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet. 14, 285–291 (1996).
  Article CAS Google Scholar
• Pulst, S.-M. et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet. 14, 269–276 (1996).
  Article CAS Google Scholar
• Sanpei, K. et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet. 14, 277–284 (1996).
  Article CAS Google Scholar
• Huynh, D.P., Del Bigio, M.R., Ho, D.H. & Pulst, S.-M. Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2. Ann. Neurol. 45, 232–241 (1999).
  Article CAS Google Scholar
• Koyano, S. et al. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci. Lett. 273, 117–120 (1999).
  Article CAS Google Scholar
• Ikeda, H. et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196–202 (1996).
  Article CAS Google Scholar
• Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 (1996).
  Article CAS Google Scholar
• Mangiarini, L. et al. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nature Genet. 15, 197–200 (1997).
  Article CAS Google Scholar
• Davies, S.W. et al. From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease. Phil. Trans. R. Soc. Lond. B Biol. Sci. 354, 981–989 (1999).
  Article CAS Google Scholar
• Burright, E.N. et al. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937–948 (1995).
  Article CAS Google Scholar
• Clark, H.B. et al. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J. Neurosci. 17, 7385–7395 (1997).
  Article CAS Google Scholar
• Vandaele, S. et al. Purkinje cell protein-2 regulatory regions and transgene expression in cerebellar compartments. Genes Dev. 5, 1136–1148 (1991).
  Article CAS Google Scholar
• Paulson, H.L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333–344 (1997).
  Article CAS Google Scholar
• Hodgson, J.G. et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selectivity striatal neurodegeneration. Neuron 23, 181–192 (1999).
  Article CAS Google Scholar
• Sanchez, I. et al. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623–633 (1999).
  Article CAS Google Scholar
• Kim, M. et al. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964–973 (1999).
  Article CAS Google Scholar
• Wellington, C.L. et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158–9167 (1998).
  Article CAS Google Scholar
• Vig, P.J. et al. Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology 50, 106–113 (1998).
  Article CAS Google Scholar
• Koeppen, A.H. The Purkinje cell and its afferents in human hereditary ataxia. J. Neuropathol. Exp. Neurol. 50, 505–514 (1991).
  Article CAS Google Scholar
• Chai, Y. et al. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8, 673–682 (1999).
  Article CAS Google Scholar
• Garcia-Mata, R. et al. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J. Cell Biol. 146, 1239–1254 (1999).
  Article CAS Google Scholar
• Johnston, J.A., Ward, C.L. & Kopito, R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883–1898 (1998).
  Article CAS Google Scholar
• Shibata, H., Huynh, D.P. & Pulst S.-M. A novel protein with RNA binding motifs interacts with ataxin-2. Hum. Mol. Genet. 9, 130–1313 (2000).
  Article Google Scholar
• Mezey, E. et al. α synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol. Psychiatry 3, 493–499 (1998).
  Article CAS Google Scholar
• Lippa, C.F. et al. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 153, 1365–1370 (1998).
  Article CAS Google Scholar